Mallinckrodt Pharmaceuticals Blog

Kratom.org - Kratom Strains & Vendors Reviewed

Skip to content
  • Home
  • Achievements
  • Advocacy
  • Culture
  • History
  • Philanthropy
  • Website

Author: Brendan Boylan

Creating a sense of community during times of isolation: Patient advocacy groups respond to the COVID-19 crisis

  • by Brendan Boylan
  • Posted on May 29, 2020August 19, 2020
  • Advocacy

Like every corner of the medical community, and communities at-large, patient advocacy organizations are dealing with the rippling effects of the COVID-19 pandemic.  From managing a sharp increase in patient inquiries to quickly shifting meetings […]

Read More

Courage in Action, Part 2

  • by Brendan Boylan
  • Posted on May 28, 2020June 3, 2020
  • Culture

Erica Ruppert, MSN, CNS, ANP-BC, chronicles her experience in a NYC intensive care unit during the height of the COVID 19 pandemic Mallinckrodt employee Erica Ruppert spent four weeks volunteering in the intensive care unit […]

Read More

Returning to the ICU during the Coronavirus Pandemic: An Interview with Jesper Nilsson, RN

  • by Brendan Boylan
  • Posted on May 7, 2020June 3, 2020
  • Culture

Prior to joining Mallinckrodt, Jesper Nilsson worked as a registered nurse at a public hospital in Stockholm.  There, he worked both in the intensive care unit and later in theapheresis treatment center.  When he heard […]

Read More

Sarcoidosis Awareness and Education More Important Than Ever During Global Health Crisis

  • by Brendan Boylan
  • Posted on April 30, 2020May 28, 2020
  • Advocacy

As the impact of the coronavirus continues to unfold, it’s critical that we recognize the increased challenges and uncertainties facing people living with rare diseases like sarcoidosis. Sarcoidosis is a complex, multi-system inflammatory disease, most […]

Read More

Posts navigation

Older posts
Newer posts
  • NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

    September 30, 2020
  • Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

    August 19, 2020
  • MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

    June 30, 2020
  • An Open Letter from Mallinckrodt CEO Mark Trudeau on Diversity and Inclusion

    June 3, 2020
  • Creating a sense of community during times of isolation: Patient advocacy groups respond to the COVID-19 crisis

    May 29, 2020

Featured Video

Categories

  • Achievements
  • Advocacy
  • Culture
  • History
  • Media
  • Philanthropy
  • Uncategorized

Latest Posts

NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

An Open Letter from Mallinckrodt CEO Mark Trudeau on Diversity and Inclusion

Creating a sense of community during times of isolation: Patient advocacy groups respond to the COVID-19 crisis

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

About Mallinckrodt Pharmaceuticals

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and hemostasis products. The company's core strengths include the acquisition and management of highly regulated raw materials and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines and its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing.

Visit Our Corporate Website

About Us

Products

Core Strengths

Corporate Social Responsibility

Investor Relations

Careers

Connect & Share

RSS
LinkedIn

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2015 Mallinckrodt.

Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.